Stock listing
Skye Bioscience, Inc.
Selected listing: 09R · DUS · EUR · DE
Skye Bioscience, Inc. (Dusseldorf:09R), Health Technology. Latest release Aug 14, 2026: Skye Bioscience and Redx Pharma Announce Transaction Agreement…
- Ticker
- Dusseldorf:09R
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Dusseldorf
- Currency
- EUR
Latest news from Skye Bioscience, Inc.
Skye Bioscience and Redx Pharma Announce Transaction Agreement and $125 Million in Financings
August 14, 2026
SkyVolt Energy Signs LOI with Modular Data Center Company Nodiac.ai, Unlocking Potential Additional Revenue from strategic Existing and Future Energy Development Assets
June 18, 2026
Skye Announces Cohort Review Committee Approved Opening of Cohort 2 Based on Favorable Safety Data from First Four Participants Treated in Cohort 1
May 20, 2026
UPDATE – Skye Bioscience Reports First Quarter 2026 Financial Results and Business Update
May 12, 2026
Skye Bioscience Reports First Quarter 2026 Financial Results and Business Update
May 11, 2026
Events
Research Skye Bioscience, Inc.
Skye Bioscience, Inc. company profile
View the public company page for Skye Bioscience, Inc. on 6ix.
Skye Bioscience, Inc. news
Read company news and market updates connected to Skye Bioscience, Inc..
Skye Bioscience, Inc. investor events
Find investor webinars, events, and replay context for Skye Bioscience, Inc..
Alternate listings
SKYE:NASDAQ
US · USD
Alternate listing for Skye Bioscience, Inc.; the primary context on this page is 09R:DUS.
A3ES4X:LSX
DE · EUR
Alternate listing for Skye Bioscience, Inc.; the primary context on this page is 09R:DUS.
A3ES4X:LS
DE · EUR
Alternate listing for Skye Bioscience, Inc.; the primary context on this page is 09R:DUS.
SKYE:BOATS
US · USD
Alternate listing for Skye Bioscience, Inc.; the primary context on this page is 09R:DUS.
09R:FWB
DE · EUR
Alternate listing for Skye Bioscience, Inc.; the primary context on this page is 09R:DUS.